BERG Overview

  • Founded
  • 2006
Founded
  • Status
  • Private
  • Employees
  • 51
Employees
  • Latest Deal Type
  • Debt - PPP
  • Latest Deal Amount
  • $1.15M
Latest Deal Amount

BERG General Information

Description

Operator of a data driven biological research company. The company is focused on research on understanding how alterations in metabolism relate to disease onset.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare
Primary Office
  • 500 Old Connecticut Path
  • Framingham, MA 01701
  • United States
+1 (617) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BERG Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Debt - PPP 03-May-2020 $1.15M Completed
1. Angel (individual) 02-Apr-2014 Completed Generating Revenue
To view BERG’s complete valuation and funding history, request access »

BERG Patents

BERG Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11091447-B2 Ube2k modulators and methods for their use Active 03-Jan-2020 0000000000 000
US-20210214320-A1 Ube2k modulators and methods for their use Granted 03-Jan-2020 0000000000
US-20210322339-A1 Combination therapy of coenzyme q10 and radiation for treatment of glioma Pending 20-Nov-2019 000000000
US-20210080466-A1 Markers for the diagnosis of prostate cancer Pending 26-Jun-2019 000000000000
CA-3129228-A1 Markers for the diagnosis of biochemical recurrence in prostate cancer Pending 06-Feb-2019 G01N33/57434
To view BERG’s complete patent history, request access »

BERG Executive Team (13)

Name Title Board Seat Contact Info
Niven Narain Ph.D Co-Founder, President and Chief Executive Officer
Vivek Vishnudas Ph.D Senior Vice President, Preclinical Discovery & Chief Technology Officer
Michael Kiebish Ph.D Chief Precision Medicine Officer
Carl Berg Co-Founder, Chairman & Principal Investor
Sarah Toomey ESQ Senior Vice President, Operations & General Counsel
You’re viewing 5 of 13 executive team members. Get the full list »

BERG Board Members (3)

Name Representing Role Since
Carl Berg BERG Co-Founder, Chairman & Principal Investor 000 0000
David Butze Self Board Member 000 0000
Eric Nestler Ph.D Self Board Member 000 0000
To view BERG’s complete board members history, request access »

BERG Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial